E
ReShape Lifesciences Inc. RSLS
$0.6355 $0.00050.08%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 72.98% 74.09% 73.21% 75.36% 60.61%
Total Depreciation and Amortization -96.37% -94.03% -93.22% -92.85% -69.81%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -101.03% -96.76% -97.44% -107.43% -74.78%
Change in Net Operating Assets 140.56% 91.74% -384.27% -683.07% -7,687.10%
Cash from Operations 64.25% 56.29% 28.66% 22.56% 22.97%
Capital Expenditure 100.00% 100.00% 72.52% 67.18% -2.52%
Sale of Property, Plant, and Equipment -100.00% -100.00% 10.00% -15.38% -15.38%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 100.00% 100.00% 97.03% 89.13% 97.11%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -60.68% -60.69% -44.69% 461.47% 425.24%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 200.00% -- -- -- --
Cash from Financing -56.98% -60.69% -44.69% 461.47% 411.68%
Foreign Exchange rate Adjustments 123.08% 122.73% 86.36% -100.00% -166.67%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 84.97% 48.90% -3.56% 103.20% 79.63%
Weiss Ratings